Results

eNauka >  Results >  Health-related quality of life (HRQoL) in patients with relapsed/refractory multiple myeloma (RRMM) treated with pomalidamide and dexamethasone +/- subcutaneous daratumumab: Patient-reported outcomes (PROs) in APOLLO
Title: Health-related quality of life (HRQoL) in patients with relapsed/refractory multiple myeloma (RRMM) treated with pomalidamide and dexamethasone +/- subcutaneous daratumumab: Patient-reported outcomes (PROs) in APOLLO
Authors Terpos, Evangelos; ...; Bila, Jelena S.  ; ...; (broj koautora 20)
Issue Date: 2021
Publication: Journal of clinical oncology (Virtual Annual Meeting of the American Society of Clinical Oncology (ASCO), Jun 04-08, 2021)
ISSN: 0732-183X Journal of Clinical Oncology Search Idenfier
Publisher: Alexandria, VA : American Society of Clinical Oncology
Type: Conference Paper
Collation: vol. 39 br. 15, Suppl str. 8046-8046
DOI: 10.1200/JCO.2021.39.15_suppl.8046
WoS-ID: 000708120604209
URI: https://enauka.gov.rs/handle/123456789/827032
URL: https://ascopubs.org/doi/10.1200/JCO.2021.39.15_suppl.8046
Project: Janssen Research & Development, LLC Other Foundation
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
Mp. category will be shown later

1
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall

Google ScholarTM

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.